Latest Russia Import Data Under HS Code 3004500002 to finland
Complete Detailed Competitor Analysis through our latest IMPORT Data of Russia.
Trade Data
| DATE | HS CODE | PRODUCT DESCRIPTION | IMPORTER | QUANTITY | UNIT | TOTAL VALUE USD | ORIGIN COUNTRY | PORT OF UNLOADING | Action |
|---|---|---|---|---|---|---|---|---|---|
| 2023-12-05 | 3004500002 | LEK. SR-VA, SOD. VITAMINS, NOT CONTAINING. ANTIBIOTICS, HARMONES, ALKALOIDS, R | LLC SaNteN | - | N/A | 528776 | Finland | G PUSHKINO | |
| 2023-12-05 | 3004500002 | LEK. SR-VA, SOD. VITAMINS, NOT CONTAINING. ANTIBIOTICS, HARMONES, ALKALOIDS, RASPHAS. In UPAK. FOR RETAIL SALES: OFTAN KA | LLC SaNteN | - | N/A | 528776 | Finland | G PUSHKINO | |
| 2023-12-04 | 3004500002 | MEDICINE FOR MEDICAL USE, TRADE NAME CYTOVIR-3 (INTERNATIONAL NON-PROPENTIC NAME ALPHA-GLUTAMYL-TRYPTOPHAN + ASCORBIC ACID + BENDAZOL), DOSAGE FORM - CAPSULES, COMPOSITION: ACTIVE INGREDIENTS : ALPHA-ALPHA-GLUTAMYL-TRYPTOPHAN SODIUM (THYMOGEN SODIUM) 0.5 | CJSC MBNPK Cytomed | - | N/A | 282860 | Finland | RAUHA | |
| 2023-12-04 | 3004500002 | MEDICINE FOR MEDICAL USE, TRADE NAME C | CJSC MBNPK Cytomed | - | N/A | 282860 | Finland | RAUHA | |
| 2023-12-04 | 3004500002 | MEDICINE FOR MEDICAL USE, TRADE NAME C | CJSC MBNPK Cytomed | - | N/A | 279032 | Finland | RAUHA | |
| 2023-12-04 | 3004500002 | MEDICINE FOR MEDICAL USE, TRADE NAME C | CJSC MBNPK Cytomed | - | N/A | 225164 | Finland | RAUHA | |
| 2023-12-04 | 3004500002 | MEDICINE FOR MEDICAL USE, TRADE NAME CYTOVIR-3 (INTERNATIONAL NON-PROPENTIC NAME ALPHA-GLUTAMYL-TRYPTOPHAN + ASCORBIC ACID + BENDAZOL), DOSAGE FORM - CAPSULES, COMPOSITION: ACTIVE INGREDIENTS : ALPHA-ALPHA-GLUTAMYL-TRYPTOPHAN SODIUM (THYMOGEN SODIUM) 0.5 | CJSC MBNPK Cytomed | - | N/A | 279032 | Finland | RAUHA | |
| 2023-12-04 | 3004500002 | MEDICINE FOR MEDICAL USE, TRADE NAME CYTOVIR-3 (INTERNATIONAL NON-PROPENTIC NAME ALPHA-GLUTAMYL-TRYPTOPHAN + ASCORBIC ACID + BENDAZOL), DOSAGE FORM - CAPSULES, COMPOSITION: ACTIVE INGREDIENTS : ALPHA-ALPHA-GLUTAMYL-TRYPTOPHAN SODIUM (THYMOGEN SODIUM) 0.5 | CJSC MBNPK Cytomed | - | N/A | 225164 | Finland | RAUHA | |
| 2023-11-09 | 3004500002 | MEDICINE FOR MEDICAL USE, TRADE NAME CYTOVIR-3 (INTERNATIONAL NON-PROPENTED NAME ALPHA-GLUTAMYL-TRYPTOPHAN + ASCORBIC ACID + BENDAZOL), DOSAGE FORM - CAPSULES. COMPOSITION: ACTIVE INGREDIENTS: ALPHA-ALPHA-GLUTAMYL-TRYPTOPHAN SODIUM (THYMOGEN SODIUM) 0.5MG; ASCORBIC ACID 50 MG, BENDAZOL HYDROCHLORIDE (DIBAZOL) 20.0 MG, AUXILIARY SUBSTANCES (LACTOSE MONOHYDRATE, CALCIUM STEARATE), RELEASE FORM - 12X2 CAPSULES IN CONTOUR BALL PACKAGING, DOES NOT CONTAIN IODINE IODINE COMPOUNDS, NARCOTICS, PSYCHOTROPIC DRUGS AND PRECURSORS, ETHYL ALCOHOL, NOT INTENDED FOR USE IN VETERINARY, USED AS AN IMMUNOSTIMULATING DRUG FOR THERAPEUTIC AND PREVENTIVE PURPOSES IN THE EARLY STAGES OF INFLUENZA AND ARVI, PACKED IN CARDBOARD PACKS FOR RETAIL SALE, COMPLETE PU PACKAGES: TWO CONTOUR BALL PACKS WITH 12 CAPSULES EACH, INSTRUCTIONS FOR USE , SERIES 080923, EXPIRED UNTIL 09.2026, | CJSC MBNPK Cytomed | - | N/A | 279359 | Finland | RAUHA | |
| 2023-11-09 | 3004500002 | MEDICINE FOR MEDICAL USE. TRADE NAME CYTOVIR-3 (INTERNATIONAL NON-PROPENTED NAME ALPHA-GLUTAMYL-TRYPTOPHAN + ASCORBIC ACID + BENDAZOL), DOSAGE FORM - CAPSULES, COMPOSITION: ACTIVE INGREDIENTS: ALPHA-ALPHA-GLUTAMYL-TRYPTOPHAN SODIUM (TI MOGEN SODIUM) 0.5MG; ASCORBIC ACID 50 MG, BENDAZOL HYDROCHLORIDE (DIBAZOL) 20.0 MG, AUXILIARY SUBSTANCES (LACTOSE MONOHYDRATE, CALCIUM STEARATE), RELEASE FORM - 12X1 CAPSULES IN CONTOUR BALL PACKAGING, DOES NOT CONTAIN IODINE IODINE COMPOUNDS, NARCOTICS, PSYCHOTROPIC DRUGS AND PRECURSORS, ETHYL ALCOHOL, NOT INTENDED FOR USE IN VETERINARY, USED AS AN IMMUNOSTIMULATING DRUG FOR THERAPEUTIC AND PREVENTIVE PURPOSES IN THE EARLY STAGES OF INFLUENZA AND ARVI, PACKED IN CARDBOARD PACKS FOR RETAIL SALE, COMPLETE PU BOXES: ONE CONTOUR BALL PACK WITH 12 CAPSULES EACH, INSTRUCTIONS FOR USE , SERIES 070923, EXPIRED UNTIL 09.2026, | CJSC MBNPK Cytomed | - | N/A | 274801 | Finland | RAUHA |

Search Global Export - Import Trade Data
Exim Trade Data provides 100% genuine and the latest IMPORT Data under HS Code 3004500002 of russia to finland. We collect IMPORT Data under HS Code 3004500002 of russia to finland with product and date. IMPORT Data helps to analyze IMPORT price, company name, port, Importer and exporter, product description, quantity, market trends, and many other data points. International Trade data of a country helps the global exporters and importers to do analysis and market research to find local suppliers and buyers in that country.
Russia Customs Shipment Data | Verified Trade Information
The authorized documentation which the Federal Customs Service of Russia maintains provides complete and trustworthy evidence of Russia's international trade activities through its Customs Shipment Data. The process requires all shipments to be documented through customs declarations which need supporting documents like invoices and transport documents and electronic files to achieve precise data results. The database includes key details such as HS codes, product descriptions, importer and exporter names, shipment values, quantities, origin and destination countries, and port or border information. Russia's shipment data provides businesses with information about actual trade movements which they can use to create trade-related business decisions because Russia functions as one of the world's major economic powers with its worldwide trade activities.


Verified Russia Import Data | Detailed Trade Insights
Actual shipment-level transactions show Russia import data which helps businesses understand the country's demand patterns. The country imports a wide range of goods, including machinery, pharmaceuticals, electronics, vehicles, and consumer products. Businesses can use this data to find active importers and learn about supplier networks and observe pricing trends throughout their operations. It helps companies identify important supply countries for Russia and shows them current demand changes between different market sectors which assists them in developing their market entry or expansion strategies.
